Non-nucleoside reverse transcriptase inhibitors

Details for Australian Patent Application No. 2006262016 (hide)

Owner Merck & Co., Inc.

Inventors Wolkenberg, Scott E.; Lindsley, Craig W.; Zhao, Zhijian

Agent Spruson & Ferguson

Pub. Number AU-A-2006262016

PCT Pub. Number WO2007/002368

Priority 60/694,600 28.06.05 US; 60/707,364 11.08.05 US

Filing date 23 June 2006

Wipo publication date 4 January 2007

International Classifications

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

24 January 2008 PCT application entered the National Phase

  PCT publication WO2007/002368 Priority application(s): WO2007/002368

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006262020-Using cytosine deaminases to diminish retroelement transfer from pigs to humans

2006262013-Large mesh deformation using the volumetric graph Laplacian